The health-insurance appeal letter anatomy, state variants, and denial-reason playbooks — one hub.
An appeal letter is the same eight-paragraph structure whether the denial cites Cal. Health & Safety Code § 1368, N.Y. Ins. Law § 4914, 28 Tex. Admin. Code § 3.1010, Florida Statutes § 627.646, 215 ILCS 134/20, ERISA § 503, the ACA § 147.136 framework, or a payer Local Coverage Determination. The well-built letter survives state variation because the envelope is the same — only the cited statute and the timeline change. This hub lays out the generic anatomy, drops in a state-coded variant for each live state landing page, and links into the three denial-reason deep-dive pages (step-therapy, medical-necessity, formulary) so the letter you mail cites the right framework the first time.
01 · The generic letter anatomy
Eight paragraphs every formal appeal letter carries — and the order they go in.
The grammar of a denial appeal letter is identical across states, ERISA self-funded plans, ACA marketplace plans, and Medicare plans. The difference is in the §-cite block (paragraph 06) and the timeline (paragraph 03). Eight paragraphs:
01
01 · Claim header (Re: line)
The Re: line names the member, the claim ID or EOB reference, the date of the Adverse Benefit Determination, and the specific service or drug denied. Carriers triage by this line — a clean Re: line puts the letter on the right appeals desk on first arrival and prevents the 14-day routing delay a generic greeting creates.
02
02 · Identification of the parties
Sender block (member, member ID, address, group/plan number, treating provider where relevant) and recipient block (carrier appeals unit, plan administrator, ERISA appeals committee — whichever matches the controlling framework). The identification paragraph establishes standing to file and the controlling channel.
03
03 · Statement of the denial
Quote or paraphrase the ABD letter — date of denial, EOB reference, the carrier's stated reason code, the dollar amount or service denied, and the deadline that attaches. This paragraph anchors every later cite: the timelines you reserve in paragraph 06 are all measured from the date named here.
04
04 · The denial reason (and why it is wrong)
State the carrier's stated reason (“medical necessity not established,” “not a covered benefit,” “step-therapy criteria not satisfied,” “drug not on formulary,” “out-of-network provider”) and immediately identify the specific defect — missing clinical-criteria document under the controlling state statute, undisclosed reviewer identifier under ERISA § 503(j)(4), undisclosed external-review rights under ACA § 147.136(b)(3).
05
05 · Statement of facts (clinical record)
Lay the clinical record in compact form — diagnosis (ICD-10), conservative-therapy history, the treating provider's letter of medical necessity, prior failure on the carrier's preferred step (with dates and outcomes), the published clinical guideline or specialty-society standard. This paragraph is what the IRO physician reviewer reads first on the second-stage level.
06
06 · Clinical grounds + the cite block
Pair the clinical grounds from paragraph 05 with the controlling cite: state statute for fully-insured (Cal. Ins. Code § 10169, N.Y. Ins. Law § 4914, Tex. Ins. Code § 4201.354, Florida Statutes § 627.646, 215 ILCS 134/20); 29 C.F.R. § 2560.503-1 for ERISA self-funded; 45 C.F.R. § 147.136 for ACA marketplace; 42 C.F.R. § 423.578(c) for Medicare Part D. The cite block is what flips the IRO / DMHC / NYDFS / TDI / OIR / DOI decision.
07
07 · Requested relief
State the specific outcome requested: full reversal of the ABD, coverage of the named service or drug at the in-network tier, internal-appeal approval on an expedited 72-hour basis where ongoing care is at stake, reservation of the external-review window (4-month federal / 180-day DMHC IMR / 4-month NY / 30-day IL / 4-month FL IRO / 4-month TDI).
08
08 · Signature + record-keeping
Signature block, member's printed name, date, and a short record-keeping note: copies of the ABD, the treating provider's letter, and (on the second-stage level) the IRO request form. The signature paragraph also reserves ERISA § 502(a) or the parallel state-court remedy where litigation becomes the follow-on.
02 · See the letter switch between playbooks
The same envelope — four citation envelopes inside it.
Below is a live preview of a generic formal appeal letter. Tap a playbook to flip the cite block: state statute (Texas), ERISA § 503 procedure, ACA § 147.136 marketplace, or medical-necessity against a payer Local Coverage Determination. The addressed envelope is identical — paragraph 06 is what changes.
August 13, 2026
Attention: Member Appeals Unit
Blue Cross and Blue Shield of Texas, Richardson, TX
Sent by: Maya Estrada
Address: 3421 W Mockingbird Lane, Dallas, TX 75235 · Member ID ending 4429
Re: Formal appeal of denial for CPT 27447 — knee arthroplasty, member M. Estrada
I am writing to formally appeal the denial of July 22, 2026 regarding the above procedure. The plan's determination letter references “Not medically necessary” yet supplies no clinical criteria document and no identifier for the reviewer. Under Texas Insurance Code § 4201.354 an adverse determination must be accompanied by the specific clinical criteria used. None are present.
The denial further fails § 4201.155(b) on its face — it does not describe the plan’s internal appeals pathway or the right to an external review by an Independent Review Organization within four months. I therefore reserve all available review remedies.
Cited: Tex. Ins. Code §§ 4201.354, 4201.155, 4201.206.
Respectfully submitted,
Maya Estrada
Tex. Ins. Code § 4201.354
Tap to switch the playbook
03 · State-coded variant callouts
The same letter — five state envelopes to drop into paragraph 06.
Every state shapes its adverse-determination framework slightly differently — the cite block is the part that has to match the controlling jurisdiction. The Texas variant below adds the TDI complaint channel, the TDI IRO process, and carrier-specific submission points to the state statute and timeline envelope.
CA · State envelope
Adds Cal. Ins. Code § 10169.2 / Cal. Health & Safety Code § 1368.01(a)(1) — 60-day internal appeal and 180-day IMR (DMHC) window.
NY · State envelope
Adds N.Y. Ins. Law § 4914 / 11 NYCRR 71.4 — 30-day internal appeal, 4-month external (ARO), and 24-hour DFS expedited external.
TX · State envelope
Adds Tex. Ins. Code §§ 4201.354, 4201.155, 4201.206 — 30-day internal and 4-month IRO (TDI) window; TDI expedited 5 days.
OH · State envelope
Adds Ohio Rev. Code §§ 3922.01–.14 / Ohio Admin. Code 3901-8-21 — Ohio DOI complaint escalation and a four-month external-review window, with ERISA routing for self-funded plans.
FL · State envelope
Adds Florida Statutes § 627.6145 / § 627.646 — 60-day internal and 4-month IRO (OIR) window; 24-hour § 627.613 expedited.
IL · State envelope
Adds 215 ILCS 134/20 / 50 Ill. Adm. Code 4525.30 — 60-day internal and 30-day IRO (Illinois DOI) window with psychiatric carve-out at 215 ILCS 125/5-6.
Top denial reasons in this state
Four denial reasons we see most in this state.
Each denial reason has its own appeal framework — pick the one that matches your EOB to land on the counter-argument, the cited framework, and the published submission channel that applies.
04 · Submit the appeal
The same denial — defended with the framework that applies to the plan.
Upload the most recent denial letter or EOB, answer the four short intake questions, and Denvow picks the state-specific adverse-determination framework (DMHC IMR in California, NYDFS external appeal in New York, TDI IRO in Texas, OIR § 627.646 IRO in Florida, Illinois DOI § 134/20 IRO), the federal ERISA § 503 procedure at 29 C.F.R. § 2560.503-1 for self-funded employer plans, or the ACA Nondiscrimination rule at 45 C.F.R. § 147.136 for marketplace plans — and the letter branches on whether you are at the first-stage internal appeal or the second-stage external-review window.
Already in the intake? Type the state abbreviation in the State field on the form — the script templates the cite block (paragraph 06) against the controlling state statute. Answer the rest of the four questions and submit. For self-funded ERISA plans, the intake sets the federal § 503 path automatically.
State-coded landing pages
Denvow is template-and-tooling, not legal counsel. For denials that genuinely need litigation, an ERISA fiduciary complaint, or a state-court remedy, we recommend a licensed attorney in the relevant jurisdiction — and will say so when we see one.